ArticleJournal of CancerPublished
Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Lewis Katz School of Medicine, Temple University, with Temple Health linked by the institution reference. Affiliation source
Publication record
- Type
- Article
- Venue
- Journal of Cancer
- Published
- Topic
- Disease research
- Subject terms
- Melanoma; Toxicities; Combination Immunotherapy; Checkpoint Blockade; Vedolizumab; Tovorafenib; Plozalizumab
- PubMed ID
- 41049010
- PubMed Central ID
- PMC12490977
- Open access
- Yes, open
- Added to directory
- Source checked